Xylem affirms Q3 EPS guidance of $1.42-$1.47 vs $1.46 estimate

0 min read     Updated on 18 Aug 2026, 08:34 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Xylem Inc reaffirms Q3 adjusted EPS guidance of $1.42-$1.47 and sales of $2.300 billion. Both figures miss analyst estimates of $1.46 and $2.316 billion respectively, indicating a conservative outlook compared to market consensus.

powered bylight_fuzz_icon
48611072

*this image is generated using AI for illustrative purposes only.

Xylem Inc (NYSE: XYL) has reaffirmed its financial guidance for the third quarter, maintaining its adjusted earnings per share (EPS) outlook at $1.42 to $1.47. The company also confirmed its sales guidance for the period at $2.300 billion.

Both metrics fall short of market expectations. The affirmed EPS range sits below the analyst consensus estimate of $1.46, while the sales outlook is lower than the estimated $2.316 billion. The company did not provide updated figures for revenue growth rates or margin expansions in this update.

Guidance Details

The reaffirmed guidance indicates no change from previous internal projections despite the variance with external estimates.

Metric: Xylem Guidance: Analyst Estimate:
Adj EPS (Q3): $1.42 - $1.47 $1.46
Sales (Q3): $2.300 billion $2.316 billion

What the Numbers Show

The divergence between Xylem’s internal guidance and analyst estimates suggests a cautious stance on near-term performance. With the midpoint of the EPS guidance ($1.445) falling below the consensus estimate ($1.46), and sales guidance trailing by $16 million, the data points to potential headwinds or conservative execution assumptions relative to market sentiment.

How might the divergence between Xylem's conservative guidance and higher analyst estimates impact short-term stock volatility and institutional investor sentiment?

What specific operational headwinds or macroeconomic factors could be driving Xylem's cautious stance on Q3 sales and EPS compared to market expectations?

Will Xylem management provide updated commentary on revenue growth rates and margin expansion trends in upcoming investor calls to address the lack of detail in this update?

like16
dislike

Xylem affirms FY26 adj EPS guidance of $5.55-$5.70 vs $5.54 est

1 min read     Updated on 18 Aug 2026, 08:34 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Xylem reaffirms FY26 adjusted EPS guidance of $5.55-$5.70, beating the $5.54 analyst estimate. Sales outlook remains at $9.2 billion, slightly below the $9.254 billion consensus. The divergence suggests margin resilience despite a modest revenue miss.

powered bylight_fuzz_icon
48611065

*this image is generated using AI for illustrative purposes only.

Xylem (NYSE: XYL) has reaffirmed its fiscal year 2026 financial guidance, maintaining its adjusted earnings per share (EPS) projection between $5.55 and $5.70. This reaffirmation positions the company’s lower-end guidance above the consensus analyst estimate of $5.54.

The water technology firm also kept its full-year revenue outlook unchanged at $9.200 billion. This figure is slightly below the market’s expected sales target of $9.254 billion.

Guidance vs Estimates

The company’s updated stance on its fiscal targets provides clarity on its near-term financial trajectory relative to market expectations.

Metric Xylem Guidance Analyst Estimate Variance
FY26 Adj EPS $5.55 - $5.70 $5.54 Lower end beats by $0.01
FY26 Sales $9.200 billion $9.254 billion Misses by $0.054 billion

What the Numbers Show

The divergence between the EPS and sales guidance highlights a potential margin expansion or cost-control narrative. While the top-line revenue guidance of $9.200 billion misses the consensus estimate of $9.254 billion, the adjusted EPS guidance comfortably clears the $5.54 benchmark. This suggests that Xylem expects profitability to remain resilient even if revenue growth does not meet the highest market expectations.

What specific cost-control measures or margin expansion strategies is Xylem implementing to offset the revenue shortfall against analyst estimates?

How might Xylem's reaffirmed guidance influence its valuation multiple compared to peers in the water technology sector?

Are there specific regional headwinds or supply chain constraints contributing to the $54 million revenue miss relative to consensus?

like18
dislike

More News on Xylem Inc